Zoladex (goserelin) in the treatment of benign gynaecological disorders: an overview of safety and efficacy.
Miller
R M
RM
Medical Research Department, ICI Pharmaceuticals, Alderley Park, Macclesfield, UK.
Frank
R A
RA
D002064:Buserelin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004715:Endometriosis / Q000188:drug therapy*; D005260:Female; D017273:Goserelin; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D017273:Goserelin; D002064:Buserelin